Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Axogen, Inc. | Director | Common Stock | 283K | $2.18M | $7.68 | Jun 4, 2024 | Direct |
Axogen, Inc. | Director | Stock Option (right to purchase) | 20.4K | $142K | $6.95 | Sep 1, 2023 | Direct |
Axogen, Inc. | Director | Restricted Stock Units | 0 | $0 | $7.68 | Jun 4, 2024 | Direct |
PDS Biotechnology Corp | Director | Employee Stock Option (Right to Buy) | 9K | Jun 24, 2024 | Direct | ||
ZyVersa Therapeutics, Inc. | Director | Stock Options | 132 | May 24, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
PDSB | PDS Biotechnology Corp | Jun 24, 2024 | 1 | $0 | 4 | Jun 25, 2024 | Director |
AXGN | Axogen, Inc. | Jun 4, 2024 | 2 | $0 | 4 | Jun 6, 2024 | Director |
AXGN | Axogen, Inc. | Mar 7, 2024 | 1 | -$225K | 4 | Mar 8, 2024 | Director |
AXGN | Axogen, Inc. | Sep 1, 2023 | 2 | $0 | 4 | Sep 7, 2023 | Director |
PDSB | PDS Biotechnology Corp | Jul 14, 2023 | 1 | $0 | 4 | Jul 17, 2023 | Director |
AXGN | Axogen, Inc. | Jun 1, 2023 | 4 | -$366K | 4 | Jun 5, 2023 | Director |
ZVSA | ZyVersa Therapeutics, Inc. | May 24, 2023 | 1 | $0 | 4 | Jul 18, 2024 | Director |
AXGN | Axogen, Inc. | May 23, 2023 | 2 | -$68.9K | 4 | May 24, 2023 | Director |
ZVSA | ZyVersa Therapeutics, Inc. | Jan 5, 2023 | 0 | $0 | 3 | Jan 17, 2023 | Director |
AXGN | Axogen, Inc. | Nov 14, 2022 | 1 | -$166K | 4 | Nov 16, 2022 | Director |
AXGN | Axogen, Inc. | Nov 8, 2022 | 1 | -$163K | 4 | Nov 10, 2022 | Director |
AXGN | Axogen, Inc. | Aug 10, 2022 | 1 | -$86.2K | 4 | Aug 11, 2022 | Director |
AXGN | Axogen, Inc. | Aug 4, 2022 | 2 | -$391K | 4 | Aug 8, 2022 | Director |
AXGN | Axogen, Inc. | Jul 25, 2022 | 3 | -$1 | 4 | Jul 26, 2022 | Director |
PDSB | PDS Biotechnology Corp | Jun 28, 2022 | 1 | $0 | 4 | Jun 29, 2022 | Director |
AXGN | Axogen, Inc. | Jun 1, 2022 | 4 | $0 | 4 | Jun 3, 2022 | Director |
AXGN | Axogen, Inc. | Jun 17, 2021 | 3 | -$6.38K | 4 | Jun 21, 2021 | Director |
PDSB | PDS Biotechnology Corp | Jun 15, 2021 | 2 | $50K | 4 | Jun 17, 2021 | Director |
AXGN | Axogen, Inc. | Jun 4, 2021 | 2 | $0 | 4 | Jun 8, 2021 | Director |
AXGN | Axogen, Inc. | Jun 1, 2021 | 2 | $0 | 4 | Jun 3, 2021 | Director |
AXGN | Axogen, Inc. | May 26, 2021 | 10 | $0 | 4 | May 28, 2021 | Director |